Literature DB >> 12819073

Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis.

Matthew H Myles1, Robert S Livingston, Beth A Livingston, Jennifer M Criley, Craig L Franklin.   

Abstract

The inflammatory bowel diseases, Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract. The causes of these diseases remain unknown; however, prevailing theories suggest that chronic intestinal inflammation results from a dysregulated immune response to ubiquitous bacterial antigens. While a substantial body of data has been amassed describing the role of the adaptive immune system in perpetuating and sustaining inflammation, very little is known about the early signals, prior to the development of inflammation, that initiate and direct the abnormal immune response. To this end, we characterized the gene expression profile of A/JCr mice with Helicobacter hepaticus-induced typhlitis at month 1 of infection, prior to the onset of histologic disease, and month 3 of infection, after chronic inflammation is fully established. Analysis of the gene expression in ceca of H. hepaticus infected mice revealed 25 up-regulated and 3 down-regulated genes in the month-1 postinoculation group and 31 up-regulated and 2 down-regulated genes in the month-3 postinoculation group. Among these was a subset of immune-related genes, including interferon-inducible protein 10, monokine induced by gamma interferon, macrophage-induced protein 1 alpha, and serum amyloid A1. Semiquantitative real-time reverse transcriptase PCR confirmed the increased expression levels of these genes, as well as elevated expression of gamma interferon. To our knowledge, this is the first report profiling cecal gene expression in H. hepaticus-infected A/JCr mice. The findings of altered gene expression prior to the development of any features of pathology and the ensuing chronic disease course make this an attractive model for studying early host response to microbe-induced inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819073      PMCID: PMC162032          DOI: 10.1128/IAI.71.7.3885-3893.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

Review 1.  Current theories on the causes of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Gastroenterol Clin North Am       Date:  1999-06       Impact factor: 3.806

Review 2.  Recent developments in the immunology of inflammatory bowel disease.

Authors:  T T MacDonald; G Monteleone; S L Pender
Journal:  Scand J Immunol       Date:  2000-01       Impact factor: 3.487

3.  Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; A Wajda
Journal:  Am J Epidemiol       Date:  1999-05-15       Impact factor: 4.897

4.  Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP.

Authors:  G A Taylor; C M Collazo; G S Yap; K Nguyen; T A Gregorio; L S Taylor; B Eagleson; L Secrest; E A Southon; S W Reid; L Tessarollo; M Bray; D W McVicar; K L Komschlies; H A Young; C A Biron; A Sher; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 5.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

6.  Activation of the transcription factor ISGF3 by interferon-gamma.

Authors:  M Matsumoto; N Tanaka; H Harada; T Kimura; T Yokochi; M Kitagawa; C Schindler; T Taniguchi
Journal:  Biol Chem       Date:  1999-06       Impact factor: 3.915

7.  Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.

Authors:  M Uguccioni; P Gionchetti; D F Robbiani; F Rizzello; S Peruzzo; M Campieri; M Baggiolini
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

8.  TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.

Authors:  R Josien; B R Wong; H L Li; R M Steinman; Y Choi
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

9.  Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.

Authors:  L R Wedderburn; N Robinson; A Patel; H Varsani; P Woo
Journal:  Arthritis Rheum       Date:  2000-04

10.  Interleukin-10 expression in intestine of Crohn disease.

Authors:  S Akagi; E Hiyama; Y Imamura; Y Takesue; Y Matsuura; T Yokoyama
Journal:  Int J Mol Med       Date:  2000-04       Impact factor: 4.101

View more
  14 in total

1.  Helicobacter hepaticus hydrogenase mutants are deficient in hydrogen-supported amino acid uptake and in causing liver lesions in A/J mice.

Authors:  Nalini S Mehta; Stephane Benoit; Jagannatha V Mysore; Renato S Sousa; Robert J Maier
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Lurking in the shadows: emerging rodent infectious diseases.

Authors:  David G Besselsen; Craig L Franklin; Robert S Livingston; Lela K Riley
Journal:  ILAR J       Date:  2008

3.  Quantitative trait loci in a bacterially induced model of inflammatory bowel disease.

Authors:  Andrew E Hillhouse; Matthew H Myles; Jeremy F Taylor; Elizabeth C Bryda; Craig L Franklin
Journal:  Mamm Genome       Date:  2011-06-30       Impact factor: 2.957

4.  Noninvasive detection of inflammation-associated colon cancer in a mouse model.

Authors:  Aaron C Ericsson; Matthew Myles; Wade Davis; Lixin Ma; Michael Lewis; Lillian Maggio-Price; Craig Franklin
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

5.  Evaluation of a commercial colorimetric fecal dipstick assay for the detection of Helicobacter hepaticus infections in laboratory mice.

Authors:  Julie E Freebersyser; Michael T Drake; Lela K Riley; Matthew H Myles; Robert S Livingston
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-05       Impact factor: 1.232

6.  Pathogenicity of Helicobacter ganmani in mice susceptible and resistant to infection with H. hepaticus.

Authors:  Cynthia G Alvarado; Andrew G Kocsis; Marcia L Hart; Marcus J Crim; Matthew H Myles; Craig L Franklin
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

Review 7.  Microbiota and reproducibility of rodent models.

Authors:  Craig L Franklin; Aaron C Ericsson
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

8.  Perturbations in cytokine gene expression after inoculation of C57BL/6 mice with Pasteurella pneumotropica.

Authors:  Calvin C Patten; Matthew H Myles; Craig L Franklin; Robert S Livingston
Journal:  Comp Med       Date:  2010-02       Impact factor: 0.982

9.  Characterization of a Helicobacter hepaticus putA mutant strain in host colonization and oxidative stress.

Authors:  Navasona Krishnan; Alan R Doster; Gerald E Duhamel; Donald F Becker
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

10.  Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice.

Authors:  Zhongming Ge; Torsten Sterzenbach; Mark T Whary; Barry H Rickman; Arlin B Rogers; Zeli Shen; Nancy S Taylor; David B Schauer; Christine Josenhans; Sebastian Suerbaum; James G Fox
Journal:  Microbes Infect       Date:  2008-04-04       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.